As part of the larger group we are committed to continuing to provide first class generics on day one of patent expiry, as well as supporting pharmacists through a series of training and education initiatives. We will continue to offer our customers high levels of service, with a sales team who are experts in reimbursement and the implications of the pharmacy contract.

We aim to be first to market and are also looking to diversify into the OTC arena with a series of POM to P switches in the pipeline so that we provide even greater choice for patients by placing pharmacists at the heart of healthcare provision.